Advertisement
A small trial shows a dose-dependent reduction in peripheral neuropathic pain in patients with diabetes

Cannabis Alleviates Peripheral Neuropathic Pain in Diabetes

0
Dose-dependent reduction in pain with inhaled cannabis in trial of 16 patients
Researchers say they've made preliminary progress toward developing a drug that one day may treat people infected with the Marburg virus

Progress Reported in Treatment of Marburg Virus

0
Researchers found infected monkeys were less likely to die with treatment
Soaring costs for cancer drugs are detrimental to patient care in the United States

Oncologists Offer Strategies for Reducing Cost of Cancer Drugs

0
Suggest letting Medicare negotiate prices; back grassroots movement calling for change
There's more evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in postmenopausal women with early breast cancer

Generic Meds Boost Survival in Some Early Breast Cancers

0
Researchers found benefit from aromatase inhibitors and bisphosphonates
Children with attention-deficit/hyperactivity disorder undergoing sedation for magnetic resonance imaging do not have a higher dose requirement for propofol

No Need for More Propofol for MRI Sedation in ADHD

0
Children with ADHD undergoing MRI do not need higher doses of sedation
Technivie (ombitasvir

FDA Approves Technivie for Hepatitis C

0
For people with chronic hepatitis C genotype 4
Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat locally advanced basal cell carcinoma that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation.

FDA Approves Odomzo for Recurring Basal Cell Carcinoma

0
Medication is designed to inhibit the Hedgehog pathway
Many U.S. hospitals overestimate their ability to provide fast delivery of tissue plasminogen activator to stroke patients

Adherence to Stroke Guidelines Overestimated by Hospitals

0
Study shows delivery of tissue plasminogen activator is often later than staff believes
A drug called solanezumab may slow Alzheimer's disease progression by about one-third

AAIC: Hints That New Drug May Slow Alzheimer’s Progression

0
Initial findings need to be supported by additional studies
For contacts of individuals with multidrug-resistant tuberculosis

Fluoroquinolones Halt Multidrug-Resistant-TB in Contacts

0
FQN preventive therapy linked to health system savings and lower mortality versus no therapy